As of 2026-05-16, the Fair Value of scPharmaceuticals Inc (SCPH) is -8.54 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 5.67 USD, the upside of scPharmaceuticals Inc is -250.67%.
With the market price of 5.67 USD and our fair value calculation, scPharmaceuticals Inc (SCPH) is not a good investment. Investing in SCPH stocks now will result in a potential loss of 250.67%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -32.21 | -28.03 | -36.84 | -54.81 | -85.15 | -47.41 |
| YoY growth | 2.39% | 12.98% | -31.43% | -48.78% | -55.35% | -24.04% |
| Market Cap (mil) | 304.37 |
| P/E | |
| Forward P/E |
| EPS | -1.71 |
| Avg earnings growth rate | -24.04% |
| TTM earnings | -91.72 |